[Intrasellar application of radioactive isotopes from a functional standpoint (mammary carcinoma, malignant exophthalmos, Cushing's syndrome, diabetes, malignant arterial hypertension)].
D001943:Breast Neoplasms / Q000532:radiotherapy; D003480:Cushing Syndrome / Q000532:radiotherapy; D003920:Diabetes Mellitus / Q000532:radiotherapy; D005094:Exophthalmos / Q000532:radiotherapy; D005500:Follow-Up Studies; D006049:Gold Isotopes / Q000627:therapeutic use*; D006801:Humans; D006974:Hypertension, Malignant / Q000532:radiotherapy; D007018:Hypopituitarism / Q000532:radiotherapy; D007495:Iridium / Q000627:therapeutic use*; D010900:Pituitary Diseases / Q000532:radiotherapy*; D010910:Pituitary Irradiation; D010913:Pituitary-Adrenal System; D012658:Sella Turcica; D015020:Yttrium Isotopes / Q000627:therapeutic use*
D006049:Gold Isotopes; D015020:Yttrium Isotopes; D007495:Iridium
Intraselläre Anwendung radioaktiver Isotope unter funktionellen Gesichtspunkten (Mammakarzinom, maligne Exophthalmie, Cushing-Syndrom, Diabetes, maligne arterielle Hypertonie)